1. Home
  2. FSV vs PCVX Comparison

FSV vs PCVX Comparison

Compare FSV & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FirstService Corporation

FSV

FirstService Corporation

HOLD

Current Price

$139.94

Market Cap

6.5B

Sector

Finance

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$53.81

Market Cap

7.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSV
PCVX
Founded
1988
2013
Country
Canada
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.5B
7.0B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
FSV
PCVX
Price
$139.94
$53.81
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
4
Target Price
$208.25
$88.25
AVG Volume (30 Days)
213.5K
1.4M
Earning Date
04-23-2026
05-07-2026
Dividend Yield
0.84%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.49
N/A
Revenue Next Year
$6.79
N/A
P/E Ratio
$49.49
N/A
Revenue Growth
N/A
N/A
52 Week Low
$119.41
$29.10
52 Week High
$205.99
$65.00

Technical Indicators

Market Signals
Indicator
FSV
PCVX
Relative Strength Index (RSI) 54.10 60.67
Support Level $133.42 $52.04
Resistance Level $157.74 $56.04
Average True Range (ATR) 4.59 2.37
MACD -0.36 0.94
Stochastic Oscillator 65.00 74.71

Price Performance

Historical Comparison
FSV
PCVX

About FSV FirstService Corporation

FirstService Corp is engaged in outsourcing property services. The company operates in two business divisions: FirstService Residential and FirstService Brands. FirstService Residential has service contracts to manage thousands of residential communities, including high and low-rise condominiums and co-operatives. FirstService Brands generates the majority of the company's revenue and provides property services to residential and commercial customers through the following brands: California Closets; Paul Davis Restoration; CertaPro Painters, Floor Coverings International, and Pillar to Post Home Inspectors. The company earns the majority of its revenue in the United States, with the remaining revenue generated in Canada.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It uses the XpressCF cell-free protein synthesis platform to develop potentially superior and novel conjugate and protein vaccine candidates for adult and pediatric indications. The company's product pipeline includes: VAX-31, VAX-24, and VAX-XL PCV vaccine candidates; VAX-A1, a Novel Group A Strep Vaccine; and VAX-GI, a Novel Shigella Vaccine, among others, in their different stages of development.

Share on Social Networks: